Canara Bank organised a Mega Retail Expo at CIDCO Exhibition Center, Vashi, Navi Mumbai on 10th February 2024. More than Forty-Five top builders of the City participated and showcassed thier projects under one roof during the event. City’s top most vehicle dealers also participated in the Expo. Canara Bank Executive Director Mr. Ashok Chandra graced the occasion and he assured the customers of quick sanction of home loans with simple procedures. The Welcome Address was delivered by Mumbai Circle Head Mr. Purushottam Chand and he also urged all the Customers to avail Housing Loan from Canara Bank. It was also informed that the Bank is offering one of the lowest ROI in the Industry, starting from 8.40% p.a. for Housing Loan. Mr Ranjeet Kumar Jha, Deputy General Manager of Mumbai Circle gave the Vote of Thanks to the Chair and assured the entire gatherings of hassle free Housing Loan Sanctions in least possible time, positively within 48 hours. The Builders were advised to go for Builder’s Tie up and Project Approvals to ensure the fast sanction. The event was witnessed by more than 1000 Customers/Potential buyers.
Related Posts
Saving lives together; Akums’ over 150 employees stand tall in organ donation pledge drive
New Delhi, 2nd March, 2024: Organ donation presents a vital opportunity to offer a new lease on life for those facing a dire shortage of hope. Akums Drugs & Pharmaceuticals Ltd., largest CDMO Serving Indian Market, acknowledges the requirement for organ donors and is dedicated to creating a meaningful impact in this essential healthcare domain. […]
Fourth Edition of FEF India Fashion Awards in collaboration with WION spotlights cultural preservation and sustainability in fashion
As the fashion landscape continues to evolve, the insights and recommendations put forth during this discussion offer a roadmap for a more inclusive, responsible, and resilient fashion ecosystem that honors our heritage while embracing a sustainable future. Day 1 of the fourth edition of FEF India Fashion Awards in collaboration with WION served as a […]
Alembic Pharmaceuticals announces USFDA Final Approval for Nelarabine Injection
2nd August 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nelarabine Injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial). The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Arranon […]